Rifamdin

Rifamdin is a derivative of Rifampicin (HY-B0272) . Rifamdin is an anti-tuberculosis agent. Rifamdin exerts its antibacterial effect by inhibiting the synthesis of bacterial RNA[1].

Product Specifications

CAS Number

[89499-17-2]

UNSPSC

12352005

Target

Bacterial; DNA/RNA Synthesis; Drug Derivative

Related Pathways

Anti-infection; Cell Cycle/DNA Damage; Others

Field of Research

Infection

Smiles

OC1=C(C2=C(C3=C(C(C)=C(C4=C31)O[C@@](C)(C4=O)O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(C(N2)=O)\C)C)O)C)O)C)OC(C)=O)C)OC)O)O)/C=N/N5CCN(CC5)CC(C)C

Molecular Formula

C46H64N4O12

Molecular Weight

865.02

References & Citations

[1]Lu Q. [A comparison of therapeutic effectiveness between rifamdin-regimen and rifampicin-regimen in pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi.